Helsinn Healthcare S.A.. (5/19/17). "Press Release: Helsinn to Present at UBS Global Healthcare Conference in New York". Lugano.

	Region	New York, NY
	Country	United States (USA)
	Organisation	Helsinn Therapeutics (U.S.) Inc.
	Group	Helsinn (Group)
	Organisation 2	UBS (Group)
	Product	UBS Global Healthcare Conference 2017 New York
	Product 2	cancer drug
	Index term	Helsinn–UBS: investor conference, 201705 supply service Helsinn Therapeutics (U.S.) Inc presents at UBS Global Healthcare Conference NY
	Person	Mann, William (Helsinn 201705 CEO of Helsinn Therapeutics (U.S.) Inc)
	Person 2	Bonvicini, Paola (Helsinn 201705 Group Head of Communication)

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, announces that William Mann, Helsinn Therapeutics (U.S.), Inc, President & CEO, will present at the UBS Global Healthcare Conference on Tuesday 23rd May at 08:30am EDT at the Grand Hyatt, New York City, USA.

Mr. Mann will give a business overview of the Helsinn Group with a special focus on Helsinn’s U.S. operations.

END

About the Helsinn Group

Helsinn is a privately owned pharmaceutical group with an extensive portfolio of marketed cancer care products and a robust drug development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. In 2016, Helsinn created the Helsinn Investment Fund to support early-stage investment opportunities in areas of unmet patient need. The company is headquartered in Lugano, Switzerland, with operating subsidiaries in Switzerland, Ireland and the U.S., a representative office in China as well as a product presence in approximately 190 countries globally.

Please visit www.helsinn.com

For more information please contact:

Helsinn Group
Paola Bonvicini
Group Head of Communication
Lugano, Switzerland
Tel: +41 (0) 91 985 21 21
Info-hhc@helsinn.com

Record changed: 2023-06-05